CBD Life Sciences Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Lisa Anne Nelson
- Full Time Employees
- 3
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 10855 N 116th Street Scottsdale AZ United States of America 85259
- IPO Date
- Sep 11, 2009
- CIK
- 0001776073
- Website
- lbcbioscienceinc.com
- Similar Companies
- Business
- CBD Life Sciences Inc. is a health and wellness company specializing in the development, manufacturing, and marketing of cannabidiol-based organic products. Its product portfolio includes hemp drops, massage oils, recovery pain relief creams, anxiety and sleep supplements, edibles, coffee, wine, skincare products, tablets, and a diverse range of pet wellness items. The company also recently expanded into hemp-free plant-based supplements with the launch of Energy Boost and Diet & Weight-Loss Gummies, targeting broader mainstream markets beyond traditional CBD consumers. Additionally, CBD Life Sciences markets mushroom-infused products such as the Mushroom-Infused Dubai Chocolate Bar and functional mushroom beverages. Founded in 2003 and headquartered in Scottsdale, Arizona, CBD Life Sciences operates primarily in the United States with ongoing efforts to expand its retail footprint nationally. Recent strategic developments include partnerships with retail chains such as Groupon, Walmart, Amazon, and spa locations in New York, exclusive product launches like the anti-inflammatory Soothe Gel, and new manufacturing agreements including collaborations with companies in the Southwest U.S. and Colombia to increase production capacity and facilitate international expansion. The company pursues growth through product innovation in cannabinoid and nutraceutical wellness sectors, aiming to capitalize on rapidly growing markets for CBD, functional mushrooms, and mainstream wellness supplements. It emphasizes scientific formulation, quality control, and expanding distribution channels in fitness, spa, hospitality, and e-commerce sectors. These initiatives position CBD Life Sciences as a diversified wellness brand transitioning from a regional CBD producer to a national multi-vertical competitor with significant growth potential. The company trades on the OTC Markets under the ticker symbol CBDL.
CBD Life Sciences Inc. (CBDL) Announces Launch of CBD Pouches Nicotine Free
CBD Life Sciences Inc. (CBDL) Enters into Stock Purchase Agreement with FBC Holding Inc. to Acquire Mushroom Madness Inc. and Formrunner Apparel; Subsidiaries Now 100% Wholly Owned
CBD Life Sciences Inc. (CBDL) Announces Launch of CBD Patches
CBD Life Sciences Inc. (CBDL) Announces Our Collection of Adaptogenic Mushroom Products
CBD Life Sciences Inc. (CBDL) Announces Smoking Scholars Bronx Dispensary as Major Distributor for High-Demand Dubai Mushroom Chocolate
CBD Life Sciences Inc. (CBDL) Expands Into JFK Airport Through Landmark Mother Earth Juice Bar Partnership in New York
CBD Life Sciences Inc. (CBDL) Secures Exclusive Launch of New Anti-Inflammatory "Soothe Gel" Across Two Red Hots Spa Locations in New York
CBD Life Sciences Inc. (CBDL) Secures Major Hemp Flower Order From Bronx Dispensary Smoking Scholars Amid Explosive Growth
CBD Life Sciences Inc. (OTC: CBDL) Launches Tremendous Energy & Weight-Loss Diet Hemp-Free Gummies
CBD Life Sciences Inc. (CBDL) Launches First-of-Its-Kind Mushroom-Infused "Dubai Chocolate Bar"
CBD Life Sciences Inc. (CBDL) Lands Major Order from Bronx Dispensary "Smoking Scholars," Signaling Explosive Growth Ahead for CBD-Infused Drinks Division
CBD Life Sciences Inc. (CBDL) Secures Landmark Agreement with Bronx Powerhouse Dispensary Smoking Scholars
CBD Life Sciences Inc. (CBDL) Announces LOI With New Jersey Dispensary, Unlocking New Revenue Channels & Strategic Growth Opportunities
CBD Life Sciences Inc. (CBDL) Huge Momentum Following NECANN New Jersey 2025
CBD Life Sciences Inc. (CBDL) Announces President Trump Confirms Marijuana Rescheduling Is Under Consideration
CBD Life Sciences Inc. (CBDL) Announces National Expansion into Las Vegas Resorts & Hotels
CBD Life Sciences Inc. (CBDL) Nears Final Lease Agreement for Second High-Traffic Retail Location in Premier Arizona Mall, Signaling Major Expansion Phase
CBDL Announces Strategic Rollout on Vibe Performance Network, Elevating 8000MG Pain Cream to National Streaming Audiences
CBD Life Sciences Inc. (CBDL) Reports 1,502.30% Revenue Increase from January to May 2025
CBD Life Sciences Inc. (CBDL) Announces New Manufacturing Deal With A Southwest-Based Company